Back to Search Start Over

A serosurvey examining exposure to Borrelia burgdorferi sensu lato and tick-borne encephalitis virus in Danish blood donors, August 2022.

Authors :
Hansen MF
Gynthersen RMM
Ocias LF
Sørensen CA
Jensen BA
Erikstrup C
Holm DK
Sækmose SG
Harritshøj LH
Kolstad L
Hoffman T
Lundkvist Å
Mens H
Lebech AM
Krogfelt KA
Source :
IJID regions [IJID Reg] 2024 Aug 06; Vol. 12, pp. 100414. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).
Publication Year :
2024

Abstract

Objectives: Borrelia burgdorferi sensu lato (Bbsl) and tick-borne encephalitis virus (TBEV) are tick-borne pathogens. This study aimed to investigate the seroprevalence of these pathogens in Danish blood donors.<br />Methods: A total of 1000 plasma samples equally distributed (n = 200) from all five Danish regions were analyzed. Commercially available enzyme-linked immunosorbent assays were used to screen the samples for immunoglobulin G antibodies against Bbsl and TBEV. The samples positive for antibodies against TBEV were further examined with a commercially available enzyme-linked immunosorbent assay and a Luminex-based TBEV suspension multiplex immunoassay for specific antibodies against non-structural protein 1 (NS1) antigen suggestive of previous infection.<br />Results: A total of 62 samples tested positive for immunoglobulin G antibodies against Bbsl. A total of 40 samples were positive or borderline for antibodies against TBEV, indicating potential infection or vaccination. Of these, one had antibodies against NS1, indicating past infection. The seroprevalence of Bbsl was 6.2% (95% confidence interval 4.8-7.8), with equal seroprevalence in all five regions. The seroprevalence of TBEV was 0.1% (95% confidence interval 0.01-0.62%).<br />Conclusions: The seroprevalence of Bbsl was similar throughout the country and corresponds well with previous studies. The seroprevalence of TBEV NS1 was low, which is in line with a low number of reported tick-borne encephalitis cases in Denmark. The NS1 positive sample was from the Capital Region, an endemic TBEV area.<br />Competing Interests: None of the authors declare they have any financial conflicts of interests. Outside the present work, AML discloses speaker honoraria and advisory board activities from Gilead, ViiV/GSK, and Pfizer and a grant from The Lundbeck Foundation (R366-2021-127). The funding bodies had no role in writing the manuscript.<br /> (© 2024 The Author(s).)

Details

Language :
English
ISSN :
2772-7076
Volume :
12
Database :
MEDLINE
Journal :
IJID regions
Publication Type :
Academic Journal
Accession number :
39257853
Full Text :
https://doi.org/10.1016/j.ijregi.2024.100414